Cytokinetics to Host Annual Symposium on Contemporary Landscapes in Muscle Biology (CLIMB)
Cytokinetics Inc CYTK
$75.85
▼ -3.55%
($-2.79)
Open
$78.40
Prev Close
$78.64
Day Range
$75.48 – $78.51
52W Range
$29.31 – $80.20
Market Cap
$9.44B
Beta
0.37
EPS (TTM)
$-6.84
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2004-04-29 |
| Shares Out. | 123,160,000 |
| Website | cytokinetics.com/ ↗ |
| Phone | 13026365400 |
Cytokinetics Inc is a publicly traded company under the ticker symbol CYTK on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
27 analysts (2026-05-01)
📰 Latest News for CYTK
Cytokinetics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
Growth Investors: Industry Analysts Just Upgraded Their Cytokinetics, Incorporated (NASDAQ:CYTK) Revenue Forecasts By 11%
JP Morgan Maintains Overweight on Cytokinetics, Raises Price Target to $97
Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026
Cytokinetics Presents New Data From Its SEQUOIA-HCM Pivotal Phase 3 Clinical Study Of Aficamten In Participants With oHCM; MAPLE-HCM At European Society Of Cardiology Heart Failure 2026 Congress
Identifix’s Direct-Hit® Mobile Brings OEM Repair Manuals to the Bay, Transforms How Repairs Get Done
HC Wainwright & Co. Maintains Buy on Cytokinetics, Raises Price Target to $140